Preoperative identification of patients with impaired (primary) haemostasis: A practical concept;Präoperative identifikation von patienten mit (primären) hämostasestörungen: Ein praktisches konzept

Hamostaseologie

Volumn 27, Issue 3, 2007, Pages 177-184

  Koscielny, J ^a   Ziemer, S ^a   Radtke, H ^a   Schmutzler, M ^a   Kiesewetter, H ^a   Salama, A ^a   Von Tempelhoff, G F ^b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b Klinik für Gynäkologie und Geburtshilfe   (Germany)

Author keywords

Bleeding history; Bleeding time; Coagulation tests; PFA 100; Preoperative haemostatic screening tests

Indexed keywords

ADENOSINE DIPHOSPHATE; ADRENALIN; COLLAGEN; VON WILLEBRAND FACTOR;

ARTICLE; BLEEDING; BLOOD CLOTTING TEST; COMPARATIVE STUDY; HEMOSTASIS; HUMAN; MAJOR CLINICAL STUDY; PARTIAL THROMBOPLASTIN TIME; PREDICTION; PREOPERATIVE EVALUATION; PREOPERATIVE PERIOD; PROTHROMBIN TIME; QUESTIONNAIRE; SCREENING TEST; SENSITIVITY ANALYSIS; THROMBOCYTE COUNT; BLEEDING TIME; BLOOD; BLOOD CLOTTING DISORDER; DRUG EFFECT; PHYSIOLOGY; PREOPERATIVE CARE; PROSPECTIVE STUDY; THROMBOCYTE; THROMBOCYTE ACTIVATION;

ADENOSINE DIPHOSPHATE; BLEEDING TIME; BLOOD PLATELETS; COLLAGEN; EPINEPHRINE; HUMANS; PLATELET ACTIVATION; PLATELET COUNT; PREOPERATIVE CARE; PROSPECTIVE STUDIES; PROTHROMBIN TIME; QUESTIONNAIRES; VASCULAR HEMOSTATIC DISORDERS;

EID: 34848848403     PISSN: 07209355     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Barber A, Green D, Galluzzo T et al. The bleeding time as a preoperative screening test. Am J Med 1985; 78: 761-764.
2. Bekanntmachung des Paul-Ehrlich-Institutes (PEI). Bericht zur Meldung nach § 21 TFG für die Jahre 1999 und 2000 Bundesgesundheitsbl - Gesundheitsforsch - Gesundheitsschutz 2003; 46: 1016-1032.
3. Beran M, Stigendal L, Petruson B. Haemostatic disorders in habitual nose-bleeders. J Laryngol Otol 1987; 101: 1020-1028.
4. Blombäck M, Eneroth P, Andersson O et al. On laboratory problems in diagnosing mild von Willebrand's disease. Am J Hematol 1992; 40: 117-120.
5. Böck M, De Haan J, Beck KH et al. Standardization of the PFA-100® platelet function test in 105 mmol/l bufffered citrate: effect of gender, smoking, and oral contraceptives. Br J Haematol 1999; 106: 898-904.
6. Borzotta AP, Keeling MM. Value of the preoperative history as an indicator of hemostatic disorders. Ann Surg 1984; 200: 648-652.
7. Cattaneo M, Federici AB, Lecchi A et al. Evaluation of the PFA-100 system in the diagnosis and therapeutic monitoring of patients with von Willebrand disease. Thromb Haemost 1999; 82: 35-39.
8. Cattaneo M, Lecchi A, Agati B et al. Evaluation of platelet function with the PFA-100 system in patients with congenital defects of platelet secretion. Thromb Res 1999; 96: 213-217.
9. Eberl W, Wendt I, Schroeder H-G. Präoperatives Screening auf Hämostasestörungen vor Adenotomie und Tonsillektomie. Klin Pädiatr 2005; 217: 20-24.
10. Edlund M, Blomback M, von Schoultz B et al. On the value of menorrhagia as a predictor for coagulation disorders. Am J Hematol 1996; 53: 234-238.
11. Eika C, Havig O, Godal HC. The value of preoperative haemostatic screening. Scand J Haematol 1978; 21: 349-354.
12. George JN, Shattil SJ. The clinical importance of acquired abnormalities of platelet function. N Engl J Med 1991; 324: 27-39.
13. Harrison P, Robinson MS, Mackie IJ et al. Performance of the platelet function analyser PFA-100 in testing abnormalities of primary haemostasis. Blood Coagul Fibrinol 1999; 10: 25-31.
14. Houry S, Georgeac C, Hay JM et al. A prospective multicenter evaluation of preoperative hemostatic screening tests. Am J Surg 1995; 170: 75-84.
15. Kadir R, Economides D, Sabin C et al. Frequency of inherited bleeding disorders in women with menorrhagia. Lancet 1998; 351: 485-489.
16. Kaplan E, Sheiner L, Boeckmann A et al. The usefulness of preoperative laboratory screening. JAMA 1985; 253: 3576-3581.
17. Kerényi A, Schlammadinger Á, Ajzner É et al. Comparison of PFA-100 closure time and template bleeding time of patients with inherited disorders causing defective platelet function. Thromb Res 1999; 96: 487.
18. Kitchens CS. To bleed or not to bleed? Is that the question for the PTT? J Thromb Haemost 2005; 3: 2607-2611.
19. Koscielny J, Blaicher AM, Felfernig D et al. Consensus use of desmopressin and antifibrinolytics in three university clinics. Anaesthesia 1998; 53: 60-62.
20. Koscielny J, Ziemer S, Radtke H et al. A practical concept for preoperative identification in patients with impaired primary haemostasis. Clin Appl-Thromb Hemost 2004; 10: 195-204.
21. Koscielny J, Kiesewetter H, Tempelhoff GF. Platelet Function Analyzer (PFA)-100® closure time in the evaluation of platelet disorders and platelet function. J Thromb Haemost 2006; 4: 1426-1427.
22. Kundu SK, Sio R, Mitu A et al. Evaluation of platelet function by PFA-100. Clin Chem 1994; 40: 1827-1828.
23. Kußmann J, Koller M, Heinke T et al. Die Bedeutung der präoperativen Gerinnungsanalytik für die Einschätzung des Blutungsriskos in der Allgemeinchirurgie. Chirurg 1997: 68: 684-688.
24. Lind SE. The bleeding time does not predict surgical bleeding. Blood 1991; 77: 2547-2552.
25. Lillicrap D, Nair SC, Srivastava A. Laboratory issues in bleeding disorders. Haemophilia 2006; 12 (Suppl 3): 68-75.
26. Macpherson CR, Jacobs P, Dent DM. Abnormal perioperative haemorrhage in asymptomatic patients is not predicted by laboratory testing. S Afr Med J 1993; 83: 106-108.
27. Mammen E, Comp P, Gosselin R et al. PFA-100™ System: A new method for assessment of platelet dysfunction. Sem Thromb Haemost 1998; 24: 195-202.
28. Mani H, Linnemann B, Luxembourg B et al. Response to aspirin and Clopidogrel monitored with different platelet function methods. Platelets. 2006; 17: 303-310.
29. Miller CH, Lenzi R, Breen C. Prevalence of von Willebrand's disease among U.S. adults. Blood 1987; 70: 377-378.
30. Pfanner G, Koscielny J, Pernerstorfer T et al. Die präoperative Blutungsanamnese. Empfehlungen der Arbeitsgruppe perioperative Gerinnung (AGPG) der Österreichischen Gesellschaft für Anästhesiologie, Reanimation und Intensivmedizin (ÖGARI). Anästhesist 2007; 56: 604-611.
31. Rodeghiero F, Castaman G. Epidemiological investigation of the prevalence of von Willebrand's disease. Blood 1987; 69: 454.
32. Rodgers RP, Levin J. A critical reappraisal of the bleeding time. Sem Throm Hemost 1990; 16: 1-20.
33. Rohrer MJ, Michelotti MC, Nahrwold DL. A prospective evaluation of the efficacy of preoperative coagulation testing. Ann Surg 1988; 208: 554-557.
34. Sadler JE. Von Willebrand disease type 1: a diagnosis in search of a disease. Blood 2003; 101: 2089-2093.
35. Srámek A, Eikenboom J, Briet E et al. Usefulness of patient interview in bleeding disorders. Arch Intern Med 1995; 155: 1409-1415.
36. Strauß J, Becke K, Schmidt J stellvertretend für den wissenschaftlichen Arbeitskreis Kinderanästhesie der Deutschen Gesellschaft für Anästhesie und Intensivmedizin. Auf die Anamnese kommt es an. Deutsches Ärzteblatt 2006; 103: A1948.
37. Velanovich V. The value of routine preoperative laboratory testing in predicting postoperative complications: A multivariate analysis. Surgery 1991; 109: 236-243.
38. Werner E, Broxson E, Tucker E et al. Prevalence of von Willebrand disease in children: Multietnic study. J Pediatrics 1993; 123: 893-898.
39. www.sggssg.ch. Position statement on laboratory testing before amulatory elective endoskopic procedures. Gastrointest Endosc 2005; 61: 189-194.